Martha Q Lacy Selected Research

Therapeutics

11/2022	Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantation.
4/2022	Outcomes following biochemical or clinical progression in patients with multiple myeloma.
1/2022	Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients.
1/2022	Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcome.
1/2022	Mortality trends in multiple myeloma after the introduction of novel therapies in the United States.
3/2021	Characterization and prognostic implication of delayed complete response in AL amyloidosis.
1/2021	Clinical Characteristics and Outcomes of Patients With Primary Plasma Cell Leukemia in the Era of Novel Agent Therapy.
1/2021	Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update.
1/2021	Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia.
12/2020	Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martha Q Lacy Research Topics

Disease

114	Multiple Myeloma 10/2022 - 11/2002
86	Immunoglobulin Light-chain Amyloidosis 01/2022 - 03/2002
41	Amyloidosis 11/2022 - 01/2002
12	Paraproteinemias (Monoclonal Gammopathy) 01/2022 - 01/2002
10	Disease Progression 04/2022 - 07/2004
10	Proteinuria 01/2022 - 01/2005
10	Neoplasms (Cancer) 01/2022 - 03/2007
9	POEMS Syndrome (Syndrome, POEMS) 01/2022 - 04/2003
8	Waldenstrom Macroglobulinemia (Macroglobulinemia) 08/2018 - 01/2002
6	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 02/2005
6	Smoldering Multiple Myeloma 01/2020 - 07/2004
4	Trisomy (Trisomies) 12/2020 - 09/2005
4	Anemia 11/2020 - 01/2003
4	Monoclonal Gammopathy of Undetermined Significance 01/2020 - 07/2004
4	Thrombocytopenia (Thrombopenia) 12/2019 - 04/2006
4	Fever (Fevers) 01/2019 - 08/2011
4	Acute Kidney Injury (Acute Renal Failure) 06/2018 - 01/2005
3	Hypoalbuminemia 01/2022 - 01/2005
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 07/2004
3	Albuminuria 12/2020 - 12/2012
3	Hypercalcemia (Milk Alkali Syndrome) 01/2020 - 01/2003
3	Renal Insufficiency (Renal Failure) 12/2019 - 06/2010
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 07/2004
2	Thrombocytosis (Thrombocythemia) 01/2022 - 05/2008
2	Vesicular Stomatitis 01/2022 - 01/2016
2	Plasma Cell Neoplasms 01/2020 - 06/2013
2	Measles 01/2019 - 07/2014
2	Cardiac Arrhythmias (Arrythmia) 10/2018 - 10/2016
2	Infections 10/2018 - 11/2002
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 09/2005
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2018 - 09/2006
2	Lymphoma (Lymphomas) 01/2018 - 09/2017
2	Cardiotoxicity 02/2017 - 10/2010
2	Hemorrhage 01/2016 - 03/2003
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2015 - 09/2008
2	Scleromyxedema (Lichen Myxedematosus) 03/2015 - 10/2005
2	Plasmacytoma 07/2014 - 04/2008
2	Peripheral Nervous System Diseases (PNS Diseases) 10/2013 - 05/2008
2	Dyspnea (Shortness of Breath) 02/2013 - 08/2011
2	Exanthema (Rash) 01/2012 - 01/2007
2	Primary Myelofibrosis (Myelosclerosis) 04/2011 - 02/2010
2	Pain (Aches) 06/2010 - 08/2006
2	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2009 - 04/2003

Drug/Important Bio-Agent (IBA)

26	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2002
22	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2002
20	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2021 - 07/2005
18	Lenalidomide (CC 5013)FDA Link 11/2018 - 01/2007
15	Immunoglobulin M (IgM)IBA 01/2021 - 01/2002
13	pomalidomideIBA 03/2021 - 10/2009
13	Melphalan (Alkeran)FDA LinkGeneric 01/2019 - 01/2002
13	Thalidomide (Thalomid)FDA Link 10/2013 - 11/2002
12	Amyloid (Amyloid Fibrils)IBA 01/2020 - 03/2003
10	Bortezomib (Velcade)FDA Link 01/2022 - 06/2013
9	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 11/2005
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 03/2006
8	CreatinineIBA 12/2020 - 01/2002
7	Immunomodulating AgentsIBA 01/2022 - 10/2009
7	Pharmaceutical PreparationsIBA 01/2022 - 10/2010
7	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 10/2010
7	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2010
6	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 09/2004
5	Proteasome InhibitorsIBA 01/2022 - 11/2015
5	Troponin T (Troponin T1)IBA 01/2021 - 05/2007
5	Alkylating AgentsIBA 05/2012 - 03/2003
4	Immunoglobulin G (IgG)IBA 01/2022 - 06/2010
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2003
4	ixazomibIBA 01/2022 - 11/2016
4	Immunoglobulin A (IgA)IBA 01/2021 - 06/2010
4	AlbuminsIBA 12/2020 - 05/2007
4	Rituximab (Mabthera)FDA Link 08/2018 - 09/2006
4	thiamine triphosphorate (TTP)IBA 06/2015 - 04/2003
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2015 - 05/2007
3	Monoclonal AntibodiesIBA 01/2022 - 09/2006
3	daratumumabIBA 01/2020 - 11/2017
3	TroponinIBA 06/2015 - 09/2004
3	DiureticsIBA 05/2007 - 01/2005
3	Serum AlbuminIBA 03/2007 - 11/2005
3	Indicators and Reagents (Reagents)IBA 09/2005 - 02/2003
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2020
2	venetoclaxIBA 01/2021 - 11/2020
2	VaccinesIBA 01/2019 - 12/2009
2	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 01/2019 - 01/2019
2	Congo RedIBA 11/2017 - 10/2016
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2017 - 03/2007
2	C-Reactive ProteinIBA 01/2016 - 02/2009
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2014 - 07/2008
2	Prednisone (Sone)FDA LinkGeneric 02/2013 - 01/2002
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2011 - 09/2010
2	Interleukin-1 (Interleukin 1)IBA 02/2009 - 02/2006
2	Interleukin-6 (Interleukin 6)IBA 02/2009 - 02/2006

Therapy/Procedure

95	Therapeutics 11/2022 - 01/2002
65	Stem Cell Transplantation 11/2022 - 11/2002
18	Drug Therapy (Chemotherapy) 01/2018 - 11/2002
11	Hematopoietic Stem Cell Transplantation 03/2021 - 03/2004
10	Transplantation 10/2022 - 03/2003
9	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 02/2012 - 01/2002
4	Kidney Transplantation 01/2022 - 07/2005
4	Aftercare (After-Treatment) 01/2021 - 05/2007
3	Autologous Transplantation 01/2017 - 12/2009
2	Hematopoietic Stem Cell Mobilization 01/2018 - 11/2005